• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调控纳米颗粒补体反应的纳米级和埃级特征。

Nanometer- and angstrom-scale characteristics that modulate complement responses to nanoparticles.

机构信息

School of Pharmacy, Newcastle University, Newcastle upon Tyne NE1 7RU, UK; Translational and Clinical Research Institute, Faculty of Health and Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK; Colorado Center for Nanomedicine and Nanosafety, University of Colorado Anschutz Medical Center, Aurora, CO, USA.

School of Pharmacy, Newcastle University, Newcastle upon Tyne NE1 7RU, UK; Translational and Clinical Research Institute, Faculty of Health and Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

出版信息

J Control Release. 2022 Nov;351:432-443. doi: 10.1016/j.jconrel.2022.09.039. Epub 2022 Sep 27.

DOI:10.1016/j.jconrel.2022.09.039
PMID:36152807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10200249/
Abstract

The contribution of the complement system to non-specific host defence and maintenance of homeostasis is well appreciated. Many particulate systems trigger complement activation but the underlying mechanisms are still poorly understood. Activation of the complement cascade could lead to particle opsonisation by the cleavage products of the third complement protein and might promote inflammatory reactions. Antibody binding in a controlled manner and/or sensing of particles by the complement pattern-recognition molecules such as C1q and mannose-binding lectin can trigger complement activation. Particle curvature and spacing arrangement/periodicity of surface functional groups/ligands are two important parameters that modulate complement responses through multivalent engagement with and conformational regulation of surface-bound antibodies and complement pattern-recognition molecules. Thus, a better fundamental understanding of nanometer- and angstrom-scale parameters that modulate particle interaction with antibodies and complement proteins could portend new possibilities for engineering of particulate drug carriers and biomedical platforms with tuneable complement responses and is discussed here.

摘要

补体系统对非特异性宿主防御和维持体内平衡的贡献是众所周知的。许多颗粒系统会触发补体激活,但潜在的机制仍知之甚少。补体级联的激活可能导致颗粒被第三补体蛋白的裂解产物调理,并可能促进炎症反应。抗体以受控的方式结合,或者补体模式识别分子(如 C1q 和甘露糖结合凝集素)感知颗粒,可以触发补体激活。颗粒曲率和表面功能基团/配体的间隔排列/周期性是两个重要参数,它们通过与表面结合的抗体和补体模式识别分子的多价结合和构象调节来调节补体反应。因此,更好地理解纳米级和埃级参数,这些参数调节颗粒与抗体和补体蛋白的相互作用,可能为工程具有可调补体反应的颗粒药物载体和生物医学平台带来新的可能性,本文对此进行了讨论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6595/10200249/f54e2a93159c/nihms-1896996-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6595/10200249/916ed1c19124/nihms-1896996-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6595/10200249/9385a1d57ab6/nihms-1896996-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6595/10200249/f09fa73d236a/nihms-1896996-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6595/10200249/dfd104b2a44d/nihms-1896996-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6595/10200249/f7d5fca29ee4/nihms-1896996-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6595/10200249/f54e2a93159c/nihms-1896996-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6595/10200249/916ed1c19124/nihms-1896996-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6595/10200249/9385a1d57ab6/nihms-1896996-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6595/10200249/f09fa73d236a/nihms-1896996-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6595/10200249/dfd104b2a44d/nihms-1896996-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6595/10200249/f7d5fca29ee4/nihms-1896996-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6595/10200249/f54e2a93159c/nihms-1896996-f0006.jpg

相似文献

1
Nanometer- and angstrom-scale characteristics that modulate complement responses to nanoparticles.调控纳米颗粒补体反应的纳米级和埃级特征。
J Control Release. 2022 Nov;351:432-443. doi: 10.1016/j.jconrel.2022.09.039. Epub 2022 Sep 27.
2
Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking.树突状聚合物末端基序依赖性逃避人补体和通过 IgM 搭便车激活补体。
Nat Commun. 2021 Aug 11;12(1):4858. doi: 10.1038/s41467-021-24960-6.
3
Activation of the complement system by nanoparticles and strategies for complement inhibition.纳米颗粒对补体系统的激活作用及补体抑制策略。
Eur J Pharm Biopharm. 2023 Dec;193:227-240. doi: 10.1016/j.ejpb.2023.11.006. Epub 2023 Nov 8.
4
Interactions of the humoral pattern recognition molecule PTX3 with the complement system.PTX3 与补体系统的体液模式识别分子相互作用。
Immunobiology. 2012 Nov;217(11):1122-8. doi: 10.1016/j.imbio.2012.07.004.
5
Interaction of Complement Defence Collagens C1q and Mannose-Binding Lectin with BMP-1/Tolloid-like Proteinases.补体防御胶原蛋白C1q和甘露糖结合凝集素与BMP-1/类托洛依德蛋白酶的相互作用
Sci Rep. 2017 Dec 5;7(1):16958. doi: 10.1038/s41598-017-17318-w.
6
The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease.自身免疫性疾病中补体蛋白和固有免疫的免疫病理学。
Clin Rev Allergy Immunol. 2020 Apr;58(2):229-251. doi: 10.1007/s12016-019-08774-5.
7
Curvature-dependent effects of nanotopography on classical immune complement activation.纳米形貌的曲率依赖性对经典免疫补体激活的影响。
Acta Biomater. 2018 Jul 1;74:112-120. doi: 10.1016/j.actbio.2018.04.053. Epub 2018 May 1.
8
Formation of Protein Corona on Nanoparticle Affects Different Complement Activation Pathways Mediated by C1q.纳米颗粒表面蛋白冠的形成会影响 C1q 介导的不同补体激活途径。
Pharm Res. 2019 Dec 23;37(1):10. doi: 10.1007/s11095-019-2747-8.
9
C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes.C1q 介导的补体激活和 C3 调理作用触发人吞噬细胞对隐形聚(2-甲基-2-恶唑啉)-包覆的二氧化硅纳米颗粒的识别。
ACS Nano. 2018 Jun 26;12(6):5834-5847. doi: 10.1021/acsnano.8b01806. Epub 2018 May 23.
10
Leishmania (Viannia) braziliensis: interaction of mannose-binding lectin with surface glycoconjugates and complement activation. An antibody-independent defence mechanism.巴西利什曼原虫(维安亚利什曼原虫):甘露糖结合凝集素与表面糖缀合物的相互作用及补体激活。一种不依赖抗体的防御机制。
Parasite Immunol. 2005 Sep;27(9):333-40. doi: 10.1111/j.1365-3024.2005.00782.x.

引用本文的文献

1
A percolation phase transition controls complement protein coating of surfaces.渗流相变控制表面的补体蛋白包被。
Cell. 2025 Jun 12. doi: 10.1016/j.cell.2025.05.026.
2
Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions.纳米医学中的机制和障碍:该领域的进展和未来方向。
ACS Nano. 2024 Jun 4;18(22):13983-13999. doi: 10.1021/acsnano.4c00182. Epub 2024 May 20.
3
Lipid and Transcriptional Regulation in a Parkinson's Disease Mouse Model by Intranasal Vesicular and Hexosomal Plasmalogen-Based Nanomedicines.

本文引用的文献

1
Structure of an anti-PEG antibody reveals an open ring that captures highly flexible PEG polymers.一种抗聚乙二醇抗体的结构揭示了一个能够捕获高度灵活的聚乙二醇聚合物的开放环。
Commun Chem. 2020 Sep 8;3(1):124. doi: 10.1038/s42004-020-00369-y.
2
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration.监测重复给予脂质纳米颗粒 COVID-19 疫苗后抗聚乙二醇抗体水平。
Int J Mol Sci. 2022 Aug 9;23(16):8838. doi: 10.3390/ijms23168838.
3
A brief history of long circulating nanoparticles.长循环纳米颗粒的简史。
鼻腔载体和六方介孔硅载质磷脂纳米药物对帕金森病模型的脂类和转录调控作用。
Adv Healthc Mater. 2024 Jun;13(14):e2304588. doi: 10.1002/adhm.202304588. Epub 2024 Feb 28.
4
Strategies to reduce the risks of mRNA drug and vaccine toxicity.降低 mRNA 药物和疫苗毒性风险的策略。
Nat Rev Drug Discov. 2024 Apr;23(4):281-300. doi: 10.1038/s41573-023-00859-3. Epub 2024 Jan 23.
5
Perspectives on complement and phagocytic cell responses to nanoparticles: From fundamentals to adverse reactions.对补体和吞噬细胞对纳米颗粒反应的观点:从基础到不良反应。
J Control Release. 2023 Apr;356:115-129. doi: 10.1016/j.jconrel.2023.02.022. Epub 2023 Mar 2.
Adv Drug Deliv Rev. 2022 Sep;188:114396. doi: 10.1016/j.addr.2022.114396. Epub 2022 Jul 5.
4
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine.SARS-CoV-2脂质纳米颗粒mRNA疫苗可增强人体中的抗聚乙二醇抗体。
ACS Nano. 2022 Aug 23;16(8):11769-11780. doi: 10.1021/acsnano.2c04543. Epub 2022 Jun 27.
5
Antibody-Dependent Complement Responses toward SARS-CoV-2 Receptor-Binding Domain Immobilized on "Pseudovirus-like" Nanoparticles.针对固定在“类假病毒”纳米颗粒上的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)受体结合域的抗体依赖性补体反应
ACS Nano. 2022 May 4. doi: 10.1021/acsnano.2c02794.
6
Pro-inflammatory concerns with lipid nanoparticles.脂质纳米颗粒的促炎问题。
Mol Ther. 2022 Jun 1;30(6):2109-2110. doi: 10.1016/j.ymthe.2022.04.011. Epub 2022 Apr 28.
7
IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines.白细胞介素 1 和白细胞介素 1 受体拮抗剂是 RNA 疫苗引发炎症反应的关键调节因子。
Nat Immunol. 2022 Apr;23(4):532-542. doi: 10.1038/s41590-022-01160-y. Epub 2022 Mar 24.
8
Combating Complement's Deleterious Effects on Nanomedicine by Conjugating Complement Regulatory Proteins to Nanoparticles.通过将补体调控蛋白与纳米颗粒偶联来对抗补体对纳米医学的有害影响。
Adv Mater. 2022 Feb;34(8):e2107070. doi: 10.1002/adma.202107070. Epub 2022 Jan 11.
9
The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory.临床前疫苗研究中使用的mRNA-LNP平台的脂质纳米颗粒成分具有高度炎症性。
iScience. 2021 Dec 17;24(12):103479. doi: 10.1016/j.isci.2021.103479. Epub 2021 Nov 20.
10
Complement opsonization of nanoparticles: Differences between humans and preclinical species.纳米颗粒的补体调理:人类与临床前物种的差异。
J Control Release. 2021 Oct 10;338:548-556. doi: 10.1016/j.jconrel.2021.08.048. Epub 2021 Sep 2.